WW stock popped 38% on October 9 with the company revealing a new compounded semaglutide product to benefit from the current shortage of weight loss drugs in the market. The company has already ...
WW International's core Weight Watchers business is struggling with falling revenues and subscribers in a competitive market. The company's acquisition of Sequence Health to pivot into weight loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback